Clinical trial
Hyperemesis Gravidarum Risk Reduction With Metformin
NCT07129473 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperemesis Gravidarum Risk Reduction With Metformin
- Lead sponsor
- University of Southern California
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- July 13, 2026
- Completion date
- March 31, 2031
- Enrollment
- 224 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.